Posters
Presentation Type
Poster
Discipline Track
Community/Public Health
Abstract Type
Case Report
Abstract
Background: Cervical cancer is the fourth most common cancer in women and although the number of cases in the United States has decreased significantly, it is estimated that 14,480 new cases of invasive cervical cancer will be diagnosed in the United States in 2021. With the Hispanic population being the fastest growing demographic group in the United States, Hispanic women are 40% more likely to be diagnosed with cervical cancer and 20% more likely to die from cervical cancer.
Case Presentation: 29-year-old Hispanic female with history of cervical cancer status post hysterectomy and chemotherapy presents with complaints of vaginal bleeding for several months associated with fever, chills, generalized body aches and left flank pain. She has a left nephrostomy tube in place from left sided hydronephrosis. Urine cultures showed gram negative rods. She failed outpatient treatment with Cefdinir and was started on IV Zosyn. However, the patient left against medical advice and was advised to follow up with her oncologist and urologist.
Conclusion: The USPSTF recommends screening for cervical cancer at the age of 21 and routine vaccination at age 11. Due to disparities such as limited access to healthcare, lack of education, language barrier, many women do not get screened or do not return for follow up appointments after an abnormal result. Providing more access to cervical cancer screening and education about risk factors associated with cervical cancer as well as the importance of primary prevention are all ways to help women have a healthier lifestyle and improve quality of life.
Academic/Professional Position
Resident
Recommended Citation
Johal, Suneet, "Cervical Cancer in Hispanic Women" (2023). Research Symposium. 29.
https://scholarworks.utrgv.edu/somrs/theme1/posters/29
Included in
Cervical Cancer in Hispanic Women
Background: Cervical cancer is the fourth most common cancer in women and although the number of cases in the United States has decreased significantly, it is estimated that 14,480 new cases of invasive cervical cancer will be diagnosed in the United States in 2021. With the Hispanic population being the fastest growing demographic group in the United States, Hispanic women are 40% more likely to be diagnosed with cervical cancer and 20% more likely to die from cervical cancer.
Case Presentation: 29-year-old Hispanic female with history of cervical cancer status post hysterectomy and chemotherapy presents with complaints of vaginal bleeding for several months associated with fever, chills, generalized body aches and left flank pain. She has a left nephrostomy tube in place from left sided hydronephrosis. Urine cultures showed gram negative rods. She failed outpatient treatment with Cefdinir and was started on IV Zosyn. However, the patient left against medical advice and was advised to follow up with her oncologist and urologist.
Conclusion: The USPSTF recommends screening for cervical cancer at the age of 21 and routine vaccination at age 11. Due to disparities such as limited access to healthcare, lack of education, language barrier, many women do not get screened or do not return for follow up appointments after an abnormal result. Providing more access to cervical cancer screening and education about risk factors associated with cervical cancer as well as the importance of primary prevention are all ways to help women have a healthier lifestyle and improve quality of life.